Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1179 | 1081 | 1254 | 1194 | 2037 | 3953 |
Fund Return | 17.89% | 8.11% | 25.38% | 6.09% | 15.29% | 14.73% |
Place in category | 177 | 13 | 197 | 87 | 134 | 69 |
% in Category | 63 | 14 | 73 | 47 | 55 | 23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA 500 Managed Volatility Portfoli | 8.39B | 19.00 | 8.19 | 11.93 | ||
EQ/Equity 500 Index Portfolio Clasb | 6.72B | 19.07 | 8.78 | 12.32 | ||
AXA Aggressive Strategy Portfolio C | 5.59B | 12.98 | 3.70 | 7.67 | ||
AXA Growth Strategy Fund Class IB | 4.85B | 11.65 | 3.02 | 6.82 | ||
AXA Large Cap Growth Managed Vol IB | 4.61B | 19.24 | 5.95 | 13.54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds Growth Fund Amer A | 147.76B | 19.33 | 5.25 | 12.91 | ||
Fidelity Contrafund | 128.94B | 28.62 | 9.37 | 14.87 | ||
Fidelity Contrafund K | 128.94B | 28.65 | 9.45 | 14.97 | ||
Vanguard Growth Index Adm | 84.02B | 21.13 | 7.62 | 15.05 | ||
JPMorgan Large Cap Growth R6 | 63.05B | 24.62 | 8.70 | 17.36 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 7.21 | 124.92 | +1.68% | |
Meta Platforms | US30303M1027 | 7.09 | 595.94 | +2.26% | |
Amazon.com | US0231351067 | 6.25 | 186.51 | +2.50% | |
Tesla | US88160R1014 | 5.96 | 250.08 | +3.91% | |
Netflix | US64110L1061 | 5.16 | 719.70 | +1.83% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review